Neurological Surgery Doctors in East Stroudsburg, PA Accepting Medicare

3 Neurological Surgery doctors found. Showing 1 - 3

Edinson Abel Najera Aguilar, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 500 Plaza Ct, East Stroudsburg, PA 18301 Phone: 610-402-6555

Ifrah Mehran, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 500 Plaza Ct, East Stroudsburg, PA 18301 Phone: 570-421-4000

Luis A Cervantes, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Plaza Court, East Stroudsburg, PA 18301 Phone: 570-426-2758    Fax: 570-426-2665

News Archive

Yale study may help reconcile conflicting findings about low-calorie sweeteners

Several studies in recent years have reported that low-calorie sweeteners in foods and beverages disrupt the human metabolism, promoting the development of diabetes and obesity.

UCLA scientists develop promising new combination treatment for glioblastoma

UCLA scientists have developed a potentially promising new combination therapy for glioblastoma, the deadliest form of brain cancer.

Patients undergoing abdominal/pelvic CT unnecessarily exposed to excess radiation

A large proportion of patients who undergo abdominal/pelvic computed tomography (CT) receive unindicated and unnecessary additional image acquisition resulting in excess, avoidable radiation exposure, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019: Pharmacor 2010

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

TxCell's pilot manufacturing facility activities put on temporary partial hold

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that it has temporarily put its pilot manufacturing facility activities at Besançon, France on partial hold.

Read more Medical News

› Verified 4 days ago